Show Summary Details
Page of

Functional Neurosurgery in Severe and Treatment-Refractory OCD 

Functional Neurosurgery in Severe and Treatment-Refractory OCD
Chapter:
Functional Neurosurgery in Severe and Treatment-Refractory OCD
Author(s):

Erica C. Keen

, Alik S. Widge

, and Darin D. Dougherty

DOI:
10.1093/med/9780190228163.003.0045
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 June 2022

Although most patients with obsessive-compulsive disorder (OCD) attain adequate symptomatic relief with conventional first-line treatments, a meaningful fraction remain incapacitated despite numerous medication trials and intensive behavioral therapy (Garnaat et al., 2014). A subset of these patients may be candidates for surgical treatment. Stereotactic neurosurgical lesions have been used successfully since the 1960s to treat patients with especially severe, chronic, treatment-refractory OCD. This chapter briefly reviews the history of psychiatric neurosurgery and the development of the four current neurosurgical approaches to OCD. It discusses issues related to the careful selection of appropriate surgical candidates. It then reviews available outcomes data for each of the four surgical procedures. The putative mechanisms of action of these ablative neurosurgeries, in the context of our current understanding of the pathophysiology of OCD, are explored. The chapter concludes with future directions in which psychiatric neurosurgery may evolve to address current limitations and harness more fully its therapeutic potential for patients with OCD.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.